Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-011459
Filing Date
2019-12-10
Accepted
2019-12-10 16:50:38
Documents
55
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmx-20191031x10q.htm 10-Q 1820554
2 EX-31.1 bpmx-20191031ex311d6e92b.htm EX-31.1 19587
3 EX-31.2 bpmx-20191031ex312f939fa.htm EX-31.2 19681
4 EX-32.1 bpmx-20191031ex32187bac3.htm EX-32.1 10171
5 EX-32.2 bpmx-20191031ex3222c17e5.htm EX-32.2 10011
  Complete submission text file 0001558370-19-011459.txt   5819980

Data Files

Seq Description Document Type Size
6 EX-101.INS bpmx-20191031.xml EX-101.INS 1206707
7 EX-101.SCH bpmx-20191031.xsd EX-101.SCH 33346
8 EX-101.CAL bpmx-20191031_cal.xml EX-101.CAL 36499
9 EX-101.DEF bpmx-20191031_def.xml EX-101.DEF 131119
10 EX-101.LAB bpmx-20191031_lab.xml EX-101.LAB 304042
11 EX-101.PRE bpmx-20191031_pre.xml EX-101.PRE 255773
Mailing Address 115 NICHOLSON LANE SAN JOSE CA 95134
Business Address 115 NICHOLSON LANE SAN JOSE CA 95134 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 191278173
SIC: 2834 Pharmaceutical Preparations